Recombinant CLEC4C (Litifilimab Biosimilar) antibody
The Humanized Chimeric anti-CLEC4C (Litifilimab Biosimilar) antibody is suitable to detect CLEC4C (Litifilimab Biosimilar) in samples from Human.
Catalog No. ABIN7597792
$357.68
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant CLEC4C (Litifilimab Biosimilar) antibody (ABIN7597792)
Target
CLEC4C (Litifilimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This CLEC4C (Litifilimab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Litifilimab Biosimilar Antibody
-
Specificity
- CLEC4C, C-type lectin superfamily member 7, CLECSF11, C-type lectin domain family 4 member C, Dendritic lectin, CD303, DLEC, HECL, Blood dendritic cell antigen 2, BDCA-2, BDCA2, CLECSF7
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
anti-CLEC4C (Litifilimab Biosimilar) antibody
Research Grade Reactivity: Human FACS, ELISA Host: Humanized Monoclonal unconjugated Recombinant Antibody
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 3.45 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- CLEC4C (Litifilimab Biosimilar)
-
Alternative Name
- Litifilimab Biosimilar
-
Target Type
- Biosimilar
-
Background
- CLEC4C, C-type lectin superfamily member 7, CLECSF11, C-type lectin domain family 4 member C, Dendritic lectin, CD303, DLEC, HECL, Blood dendritic cell antigen 2, BDCA-2, BDCA2, CLECSF7
-
UniProt
- Q8WTT0
-
CAS-No
- 2407378-48-5
Target
-
You are here:
